Oppenheimer Initiates Rockwell Medical With Outperform

Loading...
Loading...
Analysts at Oppenheimer initiated coverage on
Rockwell Medical IncRMTI
with a Outperform rating. The target price for Rockwell Medical is set to $24. Rockwell Medical shares have dropped 5.37% over the past 52 weeks, while the S&P 500 index has gained 8.99% in the same period. Rockwell Medical's shares rose 6.73% to $10.15 in pre-market trading.
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: InitiationAnalyst RatingsOppenheimer
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...